Matheson


News and Insights

Print this page

Search News & Insights


Matheson advises Questcor on $5.6 billion merger with Mallinckrodt

AUTHOR(S): George Brady, Shane Hogan, Patrick Spicer
PRACTICE AREA GROUP: Corporate, Tax
DATE: 08.04.2014

Mallinckrodt plc and Questcor Pharmaceuticals Inc have entered into a merger agreement under which Mallinckrodt will acquire Questcor for approximately $5.6 billion. The transaction is expected to complete in Q3 2014. Patrick Spicer, head of Matheson’s Corporate group, said, “We are delighted to have advised Questcor on this transaction. This deal further enhances Ireland’s reputation as a location for some of the most significant global M&A transactions.”

Matheson was Questcor’s Irish legal advisor for the transaction. The Matheson team included corporate partners Paddy Spicer and George Brady, and tax partner Shane Hogan. This continues Matheson’s track record of advising on high profile international M&A transactions. Matheson recently advised the US pharmaceutical firm Actavis plc on its $8.5 billion acquisition of Dublin-based Warner Chilcott plc and it advised Royalty Pharma on its $6.5 billion bid for Elan Corporation plc, the Irish biotechnology company. Matheson also advised Eaton Corporation plc on its $11.8 billion acquisition of Cooper Industries plc.

Following completion of the merger, Mallinckrodt shareholders will own approximately 50.5% and former Questcor shareholders will own approximately 49.5% of the combined company's stock. The transaction will create an increasingly diversified, high-growth specialty pharmaceuticals company with significantly increased scale, revenues, profitability and cash flow.

BACK TO LISTING

Matheson Snapshot


About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)